A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

Objective. MTX is widely used to treat synovitis in PsA without supporting trial evidence. The aim of our study was to test the value of MTX in the first large randomized placebo-controlled trial (RCT) in PsA. Methods. A 6-month double-blind RCT compared MTX (15 mg/week) with placebo in active PsA....

Descripción completa

Detalles Bibliográficos
Autores principales: Kingsley, Gabrielle H., Kowalczyk, Anna, Taylor, Helen, Ibrahim, Fowzia, Packham, Jonathan C., McHugh, Neil J., Mulherin, Diarmuid M., Kitas, George D., Chakravarty, Kuntal, Tom, Brian D. M., O'Keeffe, Aidan G., Maddison, Peter J., Scott, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397466/
https://www.ncbi.nlm.nih.gov/pubmed/22344575
http://dx.doi.org/10.1093/rheumatology/kes001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397466/
https://www.ncbi.nlm.nih.gov/pubmed/22344575
http://dx.doi.org/10.1093/rheumatology/kes001

Ejemplares similares